A federal district court granted preliminary approval for a class action settlement involving DaVita Inc. (NYSE:DVA) following an April 2025 ransomware attack.
The preliminary ruling marks the initial judicial step in resolving widespread litigation against the national health care organization.
• DaVita shares are consolidating. Where are DVA shares going?
Ransomware Incident Affects Millions
The ransomware group Interlock executed the cyberattack, gaining unauthorized access to the personally identifiable information and protected health information of roughly 1.2 million individuals.
Following the court’s consolidation of 10 separate lawsuits into a single action, the settlement class grew to encompass 2.3 million current and former patients.
Plaintiffs filed common law and state statutory claims, alleging that Interlock created an immediate, ongoing risk of identity theft by leaking confidential patient records on the dark web.
DaVita Denies All Legal Liability
DaVita, a major provider of kidney care services in the U.S., maintains its innocence and denies all claims of legal liability or wrongdoing.
Despite contesting the charges, the company entered formal mediation shortly after plaintiffs submitted their consolidated complaint, resulting in the proposed settlement agreement.
Court Prepares for Final Hearing
The court’s preliminary approval establishes probable cause to present the proposed agreement to class members.
Court officials will now direct formal notice to all impacted individuals, giving them an opportunity to evaluate the terms or submit objections.
During the upcoming second stage, the court will conduct a full fairness hearing to evaluate the adequacy of the relief, attorney fees, and distribution plans before deciding whether to grant final approval.
DVA Stock Price Activity: DaVita shares were up 0.47% at $182.51 at the time of publication on Friday, according to Benzinga Pro data.
Image via Shutterstock
Login to comment